Sponsors

Rapid diagnosis of cardiovascular disease

Addenbrooke’s Hospital’s emergency department (ED), part of Cambridge University Hospitals NHS Foundation Trust, is the first UK site to install two Stratus CS 200 Acute Care Diagnostic cardiac analysers. The technology from Siemens Healthcare Diagnostics is enabling rapid diagnosis of cardiovascular disease (CVD) in order to determine an appropriate treatment plan.

“The prevalence of cardiovascular disease means we sought to make it quicker and easier to gain diagnostic results for patients attending the ED who may require admission,” said Rhys Tassell, point-of-care testing (POCT) team lead. “By housing two Stratus CS 200 analysers within the ED, clinicians are able to gain results and formulate a decision as to whether a patient should be discharged or
will need a bed.

The Stratus CS200 analyser features a touchscreen interface, enabling easy navigation of menus as well as a barcode reader to eliminate the need for manual entry. The system also allows results to be reported in dual units, for easy interpretation by clinicians. It delivers a robust cardiac assay menu, including guideline-acceptable sensitive troponin I, which meets the European Society of Cardiology and American College of Cardiology Joint Committee recommendations of 10% CV at the 99th percentile of a normal population.

Other assays include D-dimer (an important test performed in patients with suspected thrombotic disorders) and human chorionic gonadotrophin (beta hCG), which is used as an early pregnancy detection marker to guide diagnostic testing decisions. CardioPhase high-sensitivity C-reactive protein (hsCRP) is available for assessing risk of future cardiovascular disease. NT-proBNP (N-terminal of the prohormone brain natriuretic peptide) aids in the diagnosis and assessment of severity of congestive heart failure and is used for risk stratification of patients with acute coronary syndrome and heart failure. Myoglobin is available for the early diagnosis of myocardial infarction and creatine kinase myocardial band (CK-MB) mass as an alternative to troponin I.
www.siemens.com

Latest Issues

Association for Molecular Pathology (AMP) 2024 Annual Meeting & Expo

Hyatt Regency, Vancouver, Canada
19-23 November, 2024

11th Digital Pathology & AI Congress: Europe

Hilton London Metropole, 255 Edgware Road, London, W2 1JU
11-12 December, 2024

Microbiology Society Annual Conference 2025

Liverpool Arena and Convention Centre
31 March - 3 April, 2025

BSMT Annual Microbiology Conference

RAF Museum, Hendon, London NW9 5LL
15 May, 2025

Ghent Pathology 2025

ICC Ghent, Belgium
24-26 June, 2025